Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD

PURPOSE: The purpose of this review is to discuss the development of Wixela™ Inhub™, a generic equivalent of Advair Diskus(®), a fixed-dose combination of fluticasone propionate/salmeterol powder for oral inhalation for patients with asthma whose symptoms are not controlled with inhaled corticostero...

Descripción completa

Detalles Bibliográficos
Autores principales: Donohue, James F., Burgoyne, Douglas S., Ward, Jonathan K., Allan, Richard, Koltun, Arkady, Cooper, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137747/
https://www.ncbi.nlm.nih.gov/pubmed/33284384
http://dx.doi.org/10.1007/s41030-020-00142-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137747/
https://www.ncbi.nlm.nih.gov/pubmed/33284384
http://dx.doi.org/10.1007/s41030-020-00142-5

Ejemplares similares